Beneficial roles of the n-3 long-chain polyunsaturated fatty acids on the management of obesity and metabolic syndrome

Medicina y ciencias biológicas

• Obesity Management 100%
• Omega-3 Fatty Acids 80%
• Unsaturated Fatty Acids 78%
• Metabolic Syndrome 67%
• VLDL Lipoproteins 20%
• Fatty Acids 13%
• Insulin Resistance 13%
• Peroxisome Proliferator-Activated Receptors 9%
• Blood Vessels 9%
• Adiponectin 8%
• oxidized low density lipoprotein 8%
• Dyslipidemias 7%
• Weight Gain 7%
• Mitochondria 6%
• Type 2 Diabetes Mellitus 6%
• Anti-Inflammatory Agents 5%
• Oxidative Stress 5%
• Cardiovascular Diseases 5%
• Ligands 5%
• Obesity 5%
• Lipids 5%
• Hypertension 5%
• Blood Pressure 5%
• Inflammation 4%
• Animals 4%
• Therapeutics 2%